Mark Hopman insider trades: Beta Bionics (BBNX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | BBNX | ↓ Sell | 370 | $16.90 | $6K | Direct | Nov 4, 2026 (2d) |
| Oct 26, 2026 | BBNX | ↓ Sell | 821 | $20.00 | $16K | Direct | Oct 28, 2026 (2d) |
| Oct 14, 2026 | BBNX | ↓ Sell | 775 | $17.35 | $13K | Direct | Oct 16, 2026 (2d) |
| Oct 1, 2026 | BBNX | ↓ Sell | 370 | $18.96 | $7K | Direct | Oct 5, 2026 (4d) |
| Sep 16, 2026 | BBNX | ↓ Sell | 30,779 | $20.13 | $620K | Direct | Sep 17, 2026 (1d) |
| Sep 14, 2026 | BBNX | ↓ Sell | 775 | $15.52 | $12K | Direct | Sep 15, 2026 (1d) |
| Sep 9, 2026 | BBNX | ↓ Sell10b5-1 | 35,994 | $18.46 | $665K | Direct | Sep 18, 2026 (9d) |
| Sep 2, 2026 | BBNX | ↓ Sell | 5,327 | $19.11 | $102K | Direct | Sep 3, 2026 (1d) |
| Jun 2, 2026 | BBNX | ↓ Sell | 5,329 | $12.61 | $67K | Direct | Jun 3, 2026 (1d) |
| Mar 4, 2026 | BBNX | ↓ Sell | 353 | $11.57 | $4K | Direct | Mar 5, 2026 (1d) |
| Mar 2, 2026 | BBNX | ↓ Sell | 834 | $12.36 | $10K | Direct | Mar 3, 2026 (1d) |
| Dec 4, 2025 | BBNX | ↓ Sell | 2,917 | $30.27 | $88K | Direct | Mar 16, 2026 (102d) |
| Sep 5, 2025 | BBNX | ↓ Sell | 18,229 | $20.34 | $371K | Direct | Sep 8, 2025 (3d) |
| Sep 2, 2025 | BBNX | ↓ Sell | 848 | $18.86 | $16K | Direct | Sep 4, 2025 (2d) |
| Aug 19, 2025 | BBNX | ↓ Sell | 16,158 | $16.61 | $268K | Direct | Aug 20, 2025 (1d) |
| Jun 2, 2025 | BBNX | ↓ Sell | 868 | $17.89 | $16K | Direct | Jun 4, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BBNX insiders
Open-market trades in the last 12 months
About Mark Hopman's insider trades
Mark Hopman is Chief Commercial Officer at Beta Bionics (BBNX). Since Jun 2, 2025, Mark has reported no open-market purchases and 16 sales worth $2.3M on SEC Form 4. In the last 12 months: 12 sales ($1.6M).
1 sale (29% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (4 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BBNX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.